Accelerate Diagnostics Announces Director Changes
| Field | Detail |
|---|---|
| Company | Accelerate Diagnostics, Inc |
| Form Type | 8-K |
| Filed Date | Apr 15, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: director-change, board-composition
TL;DR
Board shakeup at Accelerate Diagnostics: Weiss out, Harris in.
AI Summary
Accelerate Diagnostics, Inc. announced on April 10, 2025, the departure of Director Dr. Lawrence Weiss and the appointment of Dr. David Harris as a new director. The company also reported on compensatory arrangements for its officers.
Why It Matters
Changes in board composition can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: low — The filing primarily concerns routine board and officer changes, with no immediate financial distress or significant operational shifts indicated.
Key Players & Entities
- Accelerate Diagnostics, Inc. (company) — Registrant
- Dr. Lawrence Weiss (person) — Departing Director
- Dr. David Harris (person) — Newly Appointed Director
- April 10, 2025 (date) — Date of earliest event reported
FAQ
Who has been appointed as a new director to the board of Accelerate Diagnostics?
Dr. David Harris has been appointed as a new director.
Which director has departed from Accelerate Diagnostics?
Dr. Lawrence Weiss has departed from the board.
What is the exact date of the earliest event reported in this 8-K filing?
The earliest event reported is dated April 10, 2025.
What is the primary business of Accelerate Diagnostics, Inc. according to the filing?
The company is involved in Laboratory Analytical Instruments (SIC code 3826).
In which state is Accelerate Diagnostics, Inc. incorporated?
Accelerate Diagnostics, Inc. is incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 15, 2025 by Dr. Lawrence Weiss regarding Accelerate Diagnostics, Inc.